Document Detail

Disruption of rhythms of molecular clocks in primary synovial fibroblasts of patients with osteoarthritis and rheumatoid arthritis, role of IL-1β/TNF.
Jump to Full Text
MedLine Citation:
PMID:  22621205     Owner:  NLM     Status:  MEDLINE    
INTRODUCTION: Circadian rhythms play an important role in the body and in single cells. Rhythms of molecular clocks have not been investigated in synovial fibroblasts (SF) of patients with osteoarthritis (OA) and rheumatoid arthritis (RA). The study was initiated to fill this gap and to study effects of interleukin (IL)-1β/tumor necrosis factor (TNF) on rhythmicity in synovial fibroblasts of RA and OA patients.
METHODS: The presence of BMAL-1, CLOCK, Period 1 and Period 2 proteins in synovial tissue was investigated by immunofluorescence. The presence of mRNA of molecular clocks was studied during 72 h by qPCR. Characteristics of rhythms were studied with time series analysis.
RESULTS: BMAL-1, CLOCK, Period 1 and Period 2 proteins were abundantly present in synovial tissue of OA, RA and controls. Receiving synovial tissue at different operation time points during the day (8:00 am to 4:00 pm) did not reveal a rhythm of BMAL-1 or Period 1 protein. In OASF and RASF, no typical rhythm curve of molecular clock mRNA was observed. Time series analysis identified a first peak between 2 and 18 hours after synchronization but a period was not detectable due to loss of rhythm. TNF inhibited mRNA of CLOCK, Period 1 and Period 2 in OASF, while IL-1β and TNF increased these factors in RASF. This was supported by dose-dependently increased levels in MH7A RA fibroblasts. In RASF, IL-1β and TNF shifted the first peak of BMAL-1 mRNA to later time points (8 h to 14 h).
CONCLUSION: Rhythmicity is not present in primary OASF and RASF, which is unexpected because fibroblasts usually demonstrate perfect rhythms during several days. This might lead to uncoupling of important cellular pathways.
Stefanie Haas; Rainer H Straub
Related Documents :
8699135 - Inhibin and activin differentially regulate androgen production and 17 alpha-hydroxylas...
19380425 - Expression and possible role of fibroblast growth factor family members in porcine antr...
12606385 - Characterization of 17beta-hydroxysteroid dehydrogenase type 7 in reproductive tissues ...
9675155 - Human white blood cells and hair follicles are good sources of mrna for the pterin carb...
9305855 - Thrombin causes a marked delay in skeletal myogenesis that correlates with the delayed ...
23175445 - Noncanonical micrornas and endogenous sirnas in normal and psoriatic human skin.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2012-05-23
Journal Detail:
Title:  Arthritis research & therapy     Volume:  14     ISSN:  1478-6362     ISO Abbreviation:  Arthritis Res. Ther.     Publication Date:  2012  
Date Detail:
Created Date:  2012-09-18     Completed Date:  2013-05-22     Revised Date:  2013-06-24    
Medline Journal Info:
Nlm Unique ID:  101154438     Medline TA:  Arthritis Res Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  R122     Citation Subset:  IM    
Laboratory of Experimental Rheumatology and Neuroendocrino-Immunology, Division of Rheumatology, Department of Internal Medicine I, University Hospital, F, J, Strauss-Allee 11, Regensburg, 93053, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Arthritis, Rheumatoid / metabolism*,  physiopathology
Circadian Clocks / physiology
Circadian Rhythm / physiology*
Circadian Rhythm Signaling Peptides and Proteins / analysis,  biosynthesis
Fibroblasts / metabolism*
Fluorescent Antibody Technique
Interleukin-1beta / metabolism*,  pharmacology
Middle Aged
Osteoarthritis / metabolism*,  physiopathology
RNA, Messenger / analysis
Reverse Transcriptase Polymerase Chain Reaction
Synovial Membrane / metabolism
Tumor Necrosis Factor-alpha / metabolism*,  pharmacology
Reg. No./Substance:
0/Circadian Rhythm Signaling Peptides and Proteins; 0/Interleukin-1beta; 0/RNA, Messenger; 0/Tumor Necrosis Factor-alpha

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): Arthritis Res Ther
Journal ID (iso-abbrev): Arthritis Res. Ther
ISSN: 1478-6354
ISSN: 1478-6362
Publisher: BioMed Central
Article Information
Download PDF
Copyright ©2012 Haas et al.; licensee BioMed Central Ltd.
Received Day: 19 Month: 3 Year: 2012
Revision Received Day: 20 Month: 4 Year: 2012
Accepted Day: 23 Month: 5 Year: 2012
Print publication date: Year: 2012
Electronic publication date: Day: 23 Month: 5 Year: 2012
Volume: 14 Issue: 3
First Page: R122 Last Page: R122
ID: 3446503
Publisher Id: ar3852
PubMed Id: 22621205
DOI: 10.1186/ar3852

Disruption of rhythms of molecular clocks in primary synovial fibroblasts of patients with osteoarthritis and rheumatoid arthritis, role of IL-1β/TNF
Stefanie Haas1 Email:
Rainer H Straub1 Email:
1Laboratory of Experimental Rheumatology and Neuroendocrino-Immunology, Division of Rheumatology, Department of Internal Medicine I, University Hospital, F. J. Strauss-Allee 11, Regensburg, 93053, Germany


Symptoms, such as swelling, pain, stiffness, and functional ability, follow a circadian rhythm in patients with rheumatoid arthritis (RA) [1]. The circadian change of symptoms depends on increased levels of proinflammatory cytokines in the late night and early morning [1-4], which can be blocked by night time application of glucocorticoids [4-6]. Circadian changes on the level of the entire body might be translated into rhythmic phenomena in peripheral cells of inflamed tissue. While oscillations of the entire system are dependent on external synchronizers, such as light, and are called circadian rhythms, undulations of intracellular molecular clock networks are dubbed daily rhythms depending on synchronization with, for example, serum shock. These intracellular daily rhythms have never been investigated in primary material of patients with RA and osteoarthritis (OA).

The circadian rhythm is generated in the superordinate hypothalamic nucleus suprachiasmaticus [7], and this rhythm can be transferred to peripheral cells of the body by hormonal and neuronal signals [8-12]. Under physiological conditions, this was described for hepatocytes, cardiomyocytes, peripheral blood mononuclear cells, natural killer cells, CD4+ T cells and others [8-13]. After synchronization with serum shock in vitro, rhythms of molecular clocks are often self-sustained under constant culture conditions [12,14,15]. This has been demonstrated for neurons of the nucleus suprachiasmaticus [14], T cells [12] and fibroblasts [15]. Particularly, fibroblasts demonstrated a self-sustained rhythm with three regular periods and stable amplitudes over 72 hours [15]. This peripheral rhythm of fibroblasts can be modulated by systemic factors, such as glucocorticoids [16]. It is thought that these rhythms serve an overall coupling of important bodily functions which is, for example, reflected in coupling of feeding behavior and cardiomyocyte responsiveness to ingested fatty acids [8].

Coupling phenomena can be observed on the level of the entire body as a simultaneous up-regulation of cooperative hormones, such as cortisol and norepinephrine, which both rise during the early morning hours to support release of energy-rich substrates from adipose tissue and liver and both decrease at midnight kicking off nightly immune phenomena [17]. Hormones of the hypothalamic-pituitary adrenal (HPA) axis and the sympathetic nervous system (SNS) are coupled in healthy subjects but are uncoupled in patients with Crohn's disease, ulcerative colitis and systemic lupus erythematosus [18,19]. Circadian rhythms of cortisol can be altered in patients with RA [20,21]. We recently reported that coupling phenomena are important to suppress proinflammatory cytokines in primary synovial cells of patients with RA [22].

It can be hypothesized that coupling of molecular clocks that guide endogenous cellular rhythms on the peripheral cellular level play an important role in inflammation. Molecular clocks coordinate timely and functionally coupled and uncoupled cellular phenomena. Alterations of this coordination by deletion of important molecular clocks aggravate experimental arthritis as recently demonstrated for the first time in mice [23]. There is a regular cross-talk of molecular clocks and TNF in fibroblasts [23]. However, rhythms of molecular clocks have never been investigated in primary material of RA and OA patients.

This study was initiated to examine the presence of molecular clocks in primary tissue of OA and RA patients. We hypothesized that density of cells positive for molecular clocks can change during the day in these patients in a rhythmic fashion. We further hypothesized that typical daily rhythms of molecular clocks can be demonstrated in the primary fibroblast of OA and RA patients and that proinflammatory cytokines, such as IL-1β and TNF, influence the presence and rhythm of molecular clocks.

Materials and methods
Patients and control subjects

Synovial tissue was obtained from RA and OA patients during knee replacement surgery as described earlier [24]. Control synovial tissue samples were obtained from patients with joint trauma during routine arthroscopy or open joint surgery for diagnostic and therapeutic procedures. All patients were informed of the purpose of the study and gave written consent. The study was approved by the Ethics Committee of the University of Regensburg. Characteristics of patients are given in Table 1.

Immunofluorescence of synovial tissue

The tissue preparation for histological studies was performed as previously described [24]. Cryosections (5 μm) of at least three different formaldehyde-fixed synovial tissue samples from each patient/control were used. We used primary antibodies against the clock proteins BMAL-1 (1:100, polyclonal, rabbit versus human, Dianova, Hamburg, Germany), CLOCK (1:100, polyclonal, rabbit versus human, Calbiochem, Darmstadt, Germany), Period 1 (1:100, polyclonal, rabbit versus human, Millipore, Eschborn, Germany), Period 2 (1:100, polyclonal, rabbit versus human, Biozol, Eching, Germany). The secondary antibody was coupled to the fluorescent dye Alexa Fluor 546 (polyclonal, goat versus rabbit, Invitrogen, Karlsruhe, Germany). Non-specific binding sites were blocked with phosphate-buffered saline containing 10% fetal bovine serum, 10% bovine serum albumin, and 10% normal chicken serum or 10% normal goat serum for 45 minutes at room temperature. The samples were then incubated with the respective primary antibody for 3 hours at room temperature, washed and then incubated with specific secondary antibody for 90 minutes. After 4'-6-diamidino-2-phenylindole (DAPI; Roche, Mannheim, Germany) staining, slides were covered with fluorescence mounting medium (DAKO, Hamburg, Germany) and stored at 4°C until microscopy (performed within four days). Control staining was carried out with the secondary antibody alone or using unspecific rabbit serum instead of the primary antibody. Control staining always yielded a negative result.

Synovial fibroblasts

Mixed synoviocytes were isolated from synovial tissue as described before [24]. The cells were cultured over three to six passages yielding a homogenous cell population of synovial fibroblasts. In an earlier study [25], it was demonstrated that only after seven to eight passages more than 10% of the genes were differentially expressed. Thus, passage 6 was used as the upper limit. The same study also demonstrated that doubling rate was constant for up to five passages and decreased after passages 6 to 8 [25]. With this information in mind, we focused on passages 3 to 6, which was necessary due to the enormous amount of cells needed.

Preliminary experiments did not show a difference in molecular clock mRNA in synovial fibroblasts of passage 3 to 6. Per well, 150,000 cells were cultured in culture medium (RPMI 1640, Sigma, Steinheim, Germany) containing 10% fetal bovine serum, 1% penicillin/streptomycin and 0.1% amphotericin B for 24 hours. Then, cells were starved for 24 hours in medium without fetal bovine serum in order to synchronize cellular rhythms as previously reported [26]. To start daily clock rhythms, cells received a serum shock (10% fetal bovine serum) in culture medium described above. At time t = 0, cells were treated without additional cytokines (control) or with IL-1β or TNF. Starting at t = 0, cells were harvested every 2 hours for a period of 72 hours (this is a high time resolution in these types of experiments). Harvested cells were washed and stored in RNA later solution (Sigma, Steinheim, Germany) at 4°C and then at -30°C until RNA isolation.

MH7A synovial fibroblast cell line

Some of the experiments were repeated with the MH7A synovial fibroblast cell line. This cell line was derived from immortalized synovial fibroblasts of a patient with RA using the SV40 T antigen [27]. MH7A were purchased from Riken, Japan, with informed consent of Central Research Laboratories, Kissei Pharmaceutical Co., Ltd., Nagano, Japan. Similar as mentioned for primary synovial fibroblasts, synchronization was established by serum shock. Cells were incubated at indicated concentrations of IL-1β and TNF. RNA isolation was performed as described.

RNA isolation and quantitative PCR

Since most studies on molecular clocks studied mRNA and because protein determination with Western blot was extremely time-consuming (preliminary studies), we used quantitative PCR to detect levels of molecular clock mRNA. RNA was isolated according to the manufacturer's instructions (Nucleo Spin RNA II Kit, Macherey Nagel, Düren, Germany). cDNA was converted from total RNA (RevertAid First Strand cDNA Synthesis Kit; Fermentas, St. Leon-Roth, Germany). For quantitative PCR (qPCR), 1 μl of cDNA preparation, 1 μl of specific primer (100 pmol/μl; Eurofins MWG Operon, Ebersberg, Germany) and Brilliant II SYBR Green qPCR Master Mix (Agilent Technologies, Waldbronn, Germany) were applied in a total volume of 10 μl. The PCR reaction was evaluated by melting curve analysis according to the manufacturer's instructions (Thermal Cycler 7900 HAT, Applied Biosystems, Darmstadt, Germany). Each quantitative PCR was performed in triplicate.


Furthermore, Cdc2 was detected in order to estimate the interrelation to the cell cycle because this factor is detrimental for cell cycle progression [28]. The following primers were used for Cdc2: forward ACTGGCTGATTTTGGCCTTGC, reverse AGTTGAGTAACGAGCTGACCCC. The housekeeper 18s was used as control using the following primers: forward CGGCTACCACATCCAAGGAA, reverse GCTGGAATTACCGCGGCTGC. Each gene was normalized to the house keeper mRNA of 18s. The ratio of the mRNA of a specific gene divided by the mRNA of 18s at t = 0 was defined as 1.00 and ratios of every following time point were calculated in relation to t = 0.

Statistical analyses

Medians of groups were compared by Mann-Whitney U test and Box Plots were demonstrated to respect the non-normal distribution of data (Sigma Plot 11.0, Systat Software, Inc., Erkrath, Germany). For time series analysis, cubic regression was used for the interrelation of time of day and density of cells positive for molecular clocks in synovial tissue (Sigma Plot). In addition, autocorrelation analyses were used to identify a possible period of the rhythm (PASW Statistics, 18.0, IBM SPSS via IBM Germany, Ehningen, Germany). We did not use a sine or cosine wave fitting model because it was unclear whether or not oscillations really exist. Trigonometric wave fitting always yields a rhythm and, thus, it is not useful to apply this technique in a situation where the presence of oscillation is not really known. Elapsed time between serum shock synchronization and first peak of molecular clock mRNA curves was determined by inspection of mRNA curves in every individual. The significance level was P < 0.05.

Clock proteins in synovial tissue

The presence of molecular clocks is a prerequisite for endogenous cellular rhythms. This prompted us to study protein abundance in primary material of patients with OA, RA and trauma controls. Immunofluorescence demonstrated ubiquitous cellular distribution of BMAL-1, CLOCK, Period 1 and Period 2 proteins in patients with RA and OA (Figure 1). Without variation, all cells demonstrated these four clock proteins. In addition, specimens of trauma controls similarly demonstrated the four molecular clocks (data not shown).

In order to study a possible difference between OA and RA material, cellular density of synovial cells positive for molecular clocks was investigated. While synovial density of positive cells for CLOCK and Period 2 were similar between disease groups, density of BMAL-1-positive cells was higher in RA compared to OA (Figure 2A). For Period 1-positive cells, a similar trend existed (Figure 2A). This indicates that RA synovial tissue provides an environment for increased molecular clock levels.

Since BMAL-1 and Period 1 undulate during the day, we hypothesized that this oscillation can be visible when taking patient material at different operation time points during the day. We had access to material taken between 8:00 am and 4:00 pm of a large number of patients with RA and OA as well as trauma controls. Although one would have expected a difference between morning and afternoon, no statistically significant variation of synovial density of positive cells was observed in these patient groups (Figure 2B).

In preliminary experiments, we evaluated the use of Western blots for further protein analyses of molecular clocks (data not shown). However, due to the time series with 36 time points of cell removal and lack of adequate amounts of primary cells, this technique was abandoned.

Molecular clock mRNA in synovial fibroblasts

Typically, quantitative PCR is used to study undulation of molecular clock mRNA over three days [15], which was also employed in the present study. After serum shock synchronization, synovial fibroblasts start with a huge rise of molecular clock mRNA as demonstrated in Figure 3. The rise of mRNA is immediate for Period 1 and Period 2 and a little delayed for BMAL-1 in both OA and RA patients (Figure 3). Using the median of mRNA of all patients in a disease group at a single time point, we were able to demonstrate oscillation curves with a total of maximal four peaks (Figure 3, yellow areas). However, time series analysis with autocorrelation did not reveal a regular pattern to determine a period of oscillation in OA and RA patients (data not shown). In other words, oscillation is masked by a low signal-to-noise ratio in OA and RA patients.

Only in fibroblasts of healthy subjects did we find a regular rhythm for BMAL-1 and Period 1 as demonstrated by autocorrelation analyses (Additional file 1, Figure S1A). These analyses revealed a period of 24 hours for both molecular clocks (Additional file 1, Figure S1A; time between red coefficients outside the confidence limits).

Influence of IL-1β and TNF on molecular clock mRNA in synovial fibroblasts

Since time series did not reveal molecular clock mRNA oscillation in OA and RA patients, we used the average of all 36 time points of every patient for further analyses. IL-1β and TNF are abundant proinflammatory cytokines found in patients with OA and RA. Thus, these two cytokines were studied in order to investigate the influence on molecular clock mRNA. While IL-1β had no influence on average mRNA of BMAL-1, CLOCK, Period 1 and Period 2 in OA synovial fibroblasts (Figure 4A), TNF inhibited mRNA of CLOCK, Period 1 and Period 2 (Figure 4A). This is demonstrated in the oscillation curve of Period 1 mRNA (compare green line of control conditions with brown line in Figure 4B, right panel). There are no influences on the BMAL-1 mRNA oscillation curve (Figure 4B, left panel). Similar to OA synovial fibroblasts, fibroblasts of healthy controls show a slight reduction of average CLOCK mRNA by TNF (Additional file 1, Figure S1B).

In contrast to OA synovial fibroblasts, both cytokines stimulated average mRNA of RA synovial fibroblasts (Figure 5A), which is exemplified by BMAL-1 and Period 1 mRNA oscillation curves (Figure 5B). The different protein levels demonstrated in Figure 2A supports that increased mRNA levels translates into increased protein levels.

In order to intensify these investigations, the RA synovial fibroblast cell line MH7A was used (a large number of cells was obtained from these non-primary cells). Both, IL-1β and TNF dose-dependently increased mRNA of Period 1 and Period 2 (Figure 6A). This was similar for CLOCK mRNA but was not statistically significant for BMAL-1 mRNA (Additional file 2, Figure S2).

In order to investigate a possible cell cycle-dependent abundance of molecular clocks, the ubiquitous cell cycle progression factor Cdc2 was investigated. The oscillation curve of Cdc2 mRNA had one peak at approximately 30 hours after synchronization indicating one concerted proliferation event (Additional file 3, Figure S3A), which was largely different from the immediate peak of molecular clocks (compare Figure 3). Thus, there seems to be no direct interrelation between cell cycle and molecular clocks because no parallel or anti-parallel rise or fall of mRNA was observed. Interestingly, IL-1β and TNF increased Cdc2 mRNA in RA but not in OA or control subjects (Additional file 3, Figure S3B). In the direct comparison of RA and OA oscillation of Cdc2 mRNA, the peak was little delayed in RA compared to OA (Additional file 4, Figure S4, black letters).

Influence of IL-1β and TNF on molecular clock mRNA oscillation characteristics

Proinflammatory cytokines might influence oscillation characteristics of molecular clocks. As mentioned above, the period of the oscillation cannot be studied due to the rapid loss of rhythmicity (see all curves in Figure 3). Thus, elapsed time from start of synchronization to the first peak of the undulation curve was scrutinized. Both, IL-1β and TNF delayed the first peak of BMAL-1 mRNA oscillation in RA synovial fibroblasts, which did not reach the significance level in OA synovial fibroblasts (Figure 6B). IL-1β and TNF did not change oscillation characteristics of other molecular clocks investigated (Additional file 4, Figure S4).

Obviously, there exist four different groups of molecular clocks as determined by the elapsed time from start to first peak (Additional file 4, Figure S4). One group has the peak between 0 and 6 h (blue), one group between 8 and 14 h (pink), another group between 14 and 17 h (red), and a fourth group between 18 and 19 h (green). Molecular clocks in these different groups reflect the different partners of the intracellular molecular clock network (Additional file 5, Figure S5). However, conditions in RA and OA synovial fibroblasts prevent one or two full oscillation cycles, which are visible in healthy fibroblasts (Additional file 1, Figure S1A).


Molecular clocks play an important role in coordinating circadian rhythms in the body and intracellular circadian networks in peripheral cells. It is thought that the coordinated network establishes coupling and uncoupling of pathways to support cellular function in parallel and anti-parallel fashion. To our knowledge, molecular clock proteins have not been investigated in primary synovial material of patients with OA and RA but similarly not in other rheumatic diseases.

There are three reports that linked molecular clocks to rheumatology. In mouse chondrocytes, CLOCK, Period 1 and Period 2 were found to exhibit biological rhythms after serum shock [29]. The authors found CLOCK upregulated after mechanical stress which identifies CLOCK as a possible mechanosensitive gene [29]. Another report demonstrated that melatonin inhibited Cryptochrome 1 in a mouse model of experimental arthritis [30]. However, no functional tests were performed to understand the link between melatonin, cryptochrome 1 and proinflammatory mechanisms [30].

In a third study, the authors investigated mice with collagen type II-induced arthritis using synovial and spleen cells [23]. They found marked upregulation of Period 2 independent of the light dark cycle in arthritic animals. This is somewhat similar to the upregulation observed in RA patients compared to OA (Figure 2A). In addition, they found that daily rhythm of Period 1/2 mRNA shifted six hours back and that of Bmal-1 mRNA remained constantly low indicating dampened rhythm [23]. They further demonstrated that mice deficient in Cryptochrome 1 and Cryptochrome 2 demonstrated arthritis aggravation, which might be due to upregulation of TNF [23]. They concluded that the lack of Cryptochrome gene function abrogates normal biological clock function and aggravates pathological changes in arthritis.

Our report adds more information on human subjects with OA and RA. All clock proteins are ubiquitously present in synovial cells of these patients and in trauma controls (all cells are positive). It seems that density of molecular clock-positive cells was higher in RA compared to OA, which was significant for BMAL-1. Since we have not corrected for overall cellular density, this difference might depend on increased cellular infiltration in RA compared to OA though density is relatively similar in the chronic phase of both diseases. In addition, a possible undulation of density of molecular clock-positive cells did not exist in synovial tissue. This might depend on several mechanisms, such as heterogeneous chronotypes of investigated patients (two chronotypes are known: lark and owl), different medication in the various patients that might influence molecular clock levels, short observation period from 8:00 am to 4:00 pm, and low numbers of investigated patients (type II error). Since several studies demonstrated that inflammation disturbs molecular clock oscillation in different cell types in vivo and in vitro [31-36], it might well be that typical oscillations are abrogated in inflamed tissue in OA and RA.

A closer investigation of molecular clock mRNA demonstrated that synovial fibroblasts of OA and RA patients are capable of starting the typical oscillation. However, a long-standing rhythm was not established because the signal rapidly died down. Time series analysis did not demonstrate regularity in OA and RA but in healthy fibroblasts. This can depend on the contact to the proinflammatory environment to which these cells have been adapted prior to serum shock synchronization in OA and RA [31-36].

When comparing the hardly visible oscillation in these synovial fibroblasts of OA and RA patients, fibroblasts of normal rats demonstrate excellent rhythmic oscillation [15]. From this first study in rat fibroblasts, this cell type was one of the typical peripheral cell types to study daily rhythms of the intracellular molecular clock network [37-40]. This is also true for normal human fibroblasts of the skin [40], and we also found a rhythm in fibroblasts of healthy individuals. Thus, one would have expected similar rhythms in OA and RA fibroblasts. The question appears whether or not proinflammatory factors can influence molecular clock mRNA.

Our study demonstrated that proinflammatory cytokines decreased or tended to decrease mRNA of molecular clocks in OA synovial fibroblasts. This was opposite in RA synovial fibroblast which might also explain the higher density of molecular clock - positive cells in RA synovial tissue. In these experiments, we used a dose of 1 ng/ml of IL-1β or TNF. Although this is a typical cytokine concentration to stimulate cells in vitro, it does not give us a dose-response effect and it is difficult to simply translate it to a situation in vivo. Nevertheless, these concentrations appear in the proximity of cytokine-producing cells. In order to study the subject more carefully, we applied different doses in the MH7A RA synovial fibroblast cell line. Here a clear dose-response was observable.

In addition, IL-1β and TNF both changed the time point of the first BMAL-1 mRNA peak by induction of a delay of approximately three to six hours. Similar shifts of molecular clock peaks have been demonstrated in a model of experimental arthritis [23], which indicates that inflammation can directly interfere with rhythmicity of cells. This is supported by a TNF-induced inhibition of Period 1 to 3 in NIH 3T3 fibroblasts and in mice which depends on a direct influence of BMAL-1 and CLOCK binding to the E-box [36]. In addition, expression of molecular clock genes was markedly inhibited in peripheral blood leukocytes in surgical ICU patients [41].

In further time series analyses, according to the first peak of mRNA rhythm, four different groups of molecular clocks were identified. Period 1, Period 2, Period 3, cryptochrome 1 and cryptochrome 2 (blue in Additional files 4 and 5, Figures S4 and S5) demonstrated the first peak immediately after the serum shock. BMAL-1 and CLOCK demonstrated an intermediate pattern with a peak at 8 to 17 hours (pink and red in Additional files 4 and 5, Figures S4 and S5). Furthermore, the peak of Rev-Erbα mRNA appeared late between 18 and 19 hours (green in Additional files 4 and 5, Figures S4 and S5). This sequential increase of mRNA peaks is indicative of a first successful attempt to start oscillation in these OA and RA synovial fibroblasts. However, this phenomenon is impermanent, leading to rapid destruction of the rhythm.


These experiments with primary synovial tissue and fibroblasts did not demonstrate the expected oscillation of molecular clock protein or mRNA. Since proinflammatory cytokines can change the level of mRNA and time interval to peak mRNA, the proinflammatory environment most probably destroys the regular rhythm. Since synovial fibroblasts were derived from chronically inflamed tissue, molecular clock alterations are most probably programmed for a longer period of time. Disruption of coupled intracellular pathways might be a proinflammatory event.


DAPI: 4'-6-diamidino-2-phenylindole; HPA: hypothalamic-pituitary-adrenal; IL: interleukin; OA: osteoarthritis; RA: rheumatoid arthritis; SF: synovial fibroblasts; SNS: sympathetic nervous system; TNF: tumor necrosis factor.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

SH generated the data and draft figures, and drafted parts of the paper. RHS generated data and the final figures, and drafted the paper. Both authors gave final approval of the manuscript.

Supplementary Material Additional file 1

Autocorrelation of clock factors and modulation by IL-1β and TNF of mRNA expression of clock proteins over time in synovial fibroblasts from healthy subjects. A) Autocorrelation coefficient of selected clock factors. Autocorrelation is used to show a period of oscillation. mRNA expression levels of BMAL-1 and Per1 at 36 separate time points over 72 hours were used to generate autocorrelation diagrams. Every bar represents an autocorrelation coefficient generated by moving the data with the given lag number. The red lines in the graph give the 95% confidence interval of the correlation coefficients. Only red coefficients outside the red lines are significant. B) Mean of mRNA expression of clock factor and influence of IL-1β (1 ng/ml) and TNF (1 ng/ml). Of every person, the average value of mRNA expression was calculated from 36 time points during an observation period of 72 hours. The Box plot is generated from n = 4 median values of healthy subjects. Box plots give the 10th, 25th, 50th (median), 75th and 90th percentiles. ##P < 0.001 vs. respective control (Co). Abbreviations see legend to Figure 1.

Additional file 2

Modulation by IL-1β and TNF of clock proteins in synovial fibroblasts. Abbreviations see legend to Figure 1. Mean of mRNA expression of BMAL-1 and CLOCK and dose-dependent influence of IL-1β and TNF (both ng/ml) on MH7A synovial fibroblasts. The Box Plots are generated from at least 12 independent experiments over 36 hours (n = 19 for IL-1b; n = 12 for TNF). Box plots give the 10th, 25th, 50th (median), 75th and 90th percentiles. *P < 0.05, **P < 0.01, #P < 0.005 vs. highest concentration.

Additional file 3

Modulation by IL-1β and TNF of mRNA expression of the cell cycle factor Cdc2 over time in synovial fibroblasts of patients with rheumatoid arthritis (RA, n = 7), osteoarthritis (OA, n = 6), and healthy subjects (HS, n = 4). Abbreviations see legend to Figure 1. A) mRNA expression of Cdc2 over time in fibroblasts of patients with RA and OA, and HS. The lines are generated using the median value of mRNA expression of synovial fibroblast cultures at 36 time points during 72 hours. B) Average of mRNA expression of clock factor and influence of IL-1β (1 ng/ml) and TNF (1 ng/ml). Of every subject, the average value of mRNA expression was calculated from 36 time points during an observation period of 72 hours. The Box plot is generated from values of patients with RA and OA, and HS. Box plots give the 10th, 25th, 50th (median), 75th and 90th percentiles. *P < 0.05, ##P < 0.001 vs. respective control (Co).

Additional file 4

First peak after cell synchronization of individual clock factor mRNAs in OA (n = 6) and RA (n = 7) with and without additional 1 ng IL-1β/ml. Different colors indicate co-regulated factors according to Additional file 5, Figure S5. *P < 0.05 vs. OA Cdc2+IL-1β; #P < 0.005 vs. OA Cdc2; ##P < 0.001 vs. RA BMAl-1 without IL-1β; §Cdc2 is not a clock factor but a cell cycle progression factor which indicates the cell cyle progression and, thus, proliferation. Abbreviations: BMAL-1, brain and muscle ARNT-like 1; Crypt, cryptochrome; OA, osteoarthritis; Per, period homologue of Drosophila period; RA, rheumatoid arthritis; rev-erba, V-erbA-related protein 1-related; sync, synchronization.

Additional file 5

Regulation of the circadian rhythm of clock proteins. The interwoven pathways are given: 1st pathway: CLOCK (C), BMAL-1(B), Period 1 to 3 (Per1, 2, 3), and Cryptochrome 1+2 (Cry1, 2); 2nd pathway: Rev-Erba, BMAL-1. CLOCK and BMAL 1 dimerize and bind to E-boxes in the promotor region of Period (Per) genes, cryptochrome (Cry) genes, Rev-Erbα, and BMAL-1 activating their transcription. The corresponding proteins accumulate in the cytoplasm, translocate to the nucleus, and inhibit binding of CLOCK and BMAL-1 to the E-Boxes. This inhibition leads to a down-regulation of transcription of these genes. A very similar loop exists with respect to Rev-Erbα and BMAL-1 regulation. The degradation process via ubiquitination and SUMOylation leads to the know 24 hour cycle.


This study was supported by the institution and partly by the Deutsche Forschungsgemeinschaft (DFG FOR696).

Straub RH,Cutolo M,Circadian rhythms in rheumatoid arthritis: implications for pathophysiology and therapeutic managementArthritis RheumYear: 20075639940810.1002/art.2236817265475
Arvidson NG,Gudbjornsson B,Elfman L,Ryden AC,Totterman TH,Hallgren R,Circadian rhythm of serum interleukin-6 in rheumatoid arthritisAnn Rheum DisYear: 19945352152410.1136/ard.53.8.5217944637
Cutolo M,Seriolo B,Craviotto C,Pizzorni C,Sulli A,Circadian rhythms in RAAnn Rheum DisYear: 20036259359610.1136/ard.62.7.59312810417
Clarke L,Jessop D,Hunt L,Straub R,Perry M,Kirwan J,Alleviation of morning joint stiffness by low-dose prednisone in rheumatoid arthritis is associated with circadian changes in IL-6 and cortisolInt J Clin RheumatolYear: 2011624124910.2217/ijr.11.12
Arvidson NG,Gudbjornsson B,Larsson A,Hallgren R,The timing of glucocorticoid administration in rheumatoid arthritisAnn Rheum DisYear: 199756273110.1136/ard.56.1.279059137
Buttgereit F,Doering G,Schaeffler A,Witte S,Sierakowski S,Gromnica-Ihle E,Jeka S,Krueger K,Szechinski J,Alten R,Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trialLancetYear: 200837120521410.1016/S0140-6736(08)60132-418207016
Moore RY,Eichler VB,Loss of a circadian adrenal corticosterone rhythm following suprachiasmatic lesions in the ratBrain ResYear: 19724220120610.1016/0006-8993(72)90054-65047187
Durgan DJ,Trexler NA,Egbejimi O,McElfresh TA,Suk HY,Petterson LE,Shaw CA,Hardin PE,Bray MS,Chandler MP,Chow CW,Young ME,The circadian clock within the cardiomyocyte is essential for responsiveness of the heart to fatty acidsJ Biol ChemYear: 2006281242542426910.1074/jbc.M60170420016798731
Terazono H,Mutoh T,Yamaguchi S,Kobayashi M,Akiyama M,Udo R,Ohdo S,Okamura H,Shibata S,Adrenergic regulation of clock gene expression in mouse liverProc Natl Acad Sci USAYear: 20031006795680010.1073/pnas.093679710012754374
Boivin DB,James FO,WU A,Cho-Park PF,Xiong H,Sun ZS,Circadian clock genes oscillate in human peripheral blood mononuclear cellsBloodYear: 20031024143414510.1182/blood-2003-03-077912893774
Arjona A,Sarkar DK,Circadian oscillations of clock genes, cytolytic factors, and cytokines in rat NK cellsJ ImmunolYear: 20051747618762415944262
Bollinger T,Leutz A,Leliavski A,Skrum L,Kovac J,Bonacina L,Benedict C,Lange T,Westermann J,Oster H,Solbach W,Circadian clocks in mouse and human CD4+ T cellsPLoS OneYear: 20116e2980110.1371/journal.pone.002980122216357
Logan RW,Arjona A,Sarkar DK,Role of sympathetic nervous system in the entrainment of circadian natural-killer cell functionBrain Behav ImmunYear: 20112510110910.1016/j.bbi.2010.08.00720816749
Groos GA,Hendriks J,Regularly firing neurones in the rat suprachiasmatic nucleusExperientiaYear: 1979351597159810.1007/BF01953215520464
Balsalobre A,Damiola F,Schibler U,A serum shock induces circadian gene expression in mammalian tissue culture cellsCellYear: 19989392993710.1016/S0092-8674(00)81199-X9635423
Balsalobre A,Brown SA,Marcacci L,Tronche F,Kellendonk C,Reichardt HM,Schutz G,Schibler U,Resetting of circadian time in peripheral tissues by glucocorticoid signalingScienceYear: 20002892344234710.1126/science.289.5488.234411009419
Straub RH,Cutolo M,Buttgereit F,Pongratz G,Energy regulation and neuroendocrine-immune control in chronic inflammatory diseasesJ Intern MedYear: 201026754356010.1111/j.1365-2796.2010.02218.x20210843
Straub RH,Herfarth H,Falk W,Andus T,Schölmerich J,Uncoupling of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis in inflammatory bowel disease?J NeuroimmunolYear: 200212611612510.1016/S0165-5728(02)00047-412020963
Härle P,Straub RH,Wiest R,Maier A,Schölmerich J,Atzeni F,Carrabba M,Cutolo M,Sarzi-Puttini P,Increase of sympathetic outflow measured by NPY and decrease of the hypothalamic-pituitary-adrenal axis tone in patients with SLE and RA - another example of uncoupling of response systemsAnn Rheum DisYear: 200565515615941834
Neeck G,Federlin K,Graef V,Rusch D,Schmidt KL,Adrenal secretion of cortisol in patients with rheumatoid arthritisJ RheumatolYear: 19901724292313668
Dekkers JC,Geenen R,Godaert GL,van Doornen LJ,Bijlsma JW,Diurnal rhythm of salivary cortisol levels in patients with recent-onset rheumatoid arthritisArthritis RheumYear: 20004346546710.1002/1529-0131(200002)43:2<465::AID-ANR31>3.0.CO;2-Q10693891
Straub RH,Günzler C,Miller LE,Cutolo M,Schölmerich J,Schill S,Anti-inflammatory cooperativity of corticosteroids and norepinephrine in rheumatoid arthritis synovial tissue in vivo and in vitroFASEB JYear: 200216993100010.1096/fj.02-0085com12087060
Hashiramoto A,Yamane T,Tsumiyama K,Yoshida K,Komai K,Yamada H,Yamazaki F,Doi M,Okamura H,Shiozawa S,Mammalian clock gene Cryptochrome regulates arthritis via proinflammatory cytokine TNF-alphaJ ImmunolYear: 20101841560156510.4049/jimmunol.090328420042581
Miller LE,Jüsten HP,Schölmerich J,Straub RH,The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophagesFASEB JYear: 2000142097210710.1096/fj.99-1082com11023994
Neumann E,Riepl B,Knedla A,Lefevre S,Tarner IH,Grifka J,Steinmeyer J,Scholmerich J,Gay S,Muller-Ladner U,Cell culture and passaging alters gene expression pattern and proliferation rate in rheumatoid arthritis synovial fibroblastsArthritis Res TherYear: 201012R8310.1186/ar301020462438
Balsalobre A,Marcacci L,Schibler U,Multiple signaling pathways elicit circadian gene expression in cultured Rat-1 fibroblastsCurr BiolYear: 2000101291129410.1016/S0960-9822(00)00758-211069111
Miyazawa K,Mori A,Okudaira H,Establishment and characterization of a novel human rheumatoid fibroblast-like synoviocyte line, MH7A, immortalized with SV40 T antigenJ BiochemYear: 19981241153116210.1093/oxfordjournals.jbchem.a0222339832620
Hu X,Moscinski LC,Cdc2: a monopotent or pluripotent CDK?Cell ProlifYear: 20114420521110.1111/j.1365-2184.2011.00753.x21535261
Kanbe K,Inoue K,Xiang C,Chen Q,Identification of clock as a mechanosensitive gene by large-scale DNA microarray analysis: downregulation in osteoarthritic cartilageMod RheumatolYear: 20061613113610.1007/s10165-006-0469-316767550
Bang J,Chang HW,Jung HR,Cho CH,Hur JA,Lee SI,Choi TH,Kim SH,Ha E,Melatonin attenuates clock gene Cryptochrome1, which may aggravates mouse anti-type II collagen antibody-induced arthritisRheumatol IntYear: 20123237938510.1007/s00296-010-1641-921113809
Lundkvist GB,Sellix MT,Nygard M,Davis E,Straume M,Kristensson K,Block GD,Clock gene expression during chronic inflammation induced by infection with Trypanosoma brucei brucei in ratsJ Biol RhythmsYear: 2010259210210.1177/074873040936096320348460
Haimovich B,Calvano J,Haimovich AD,Calvano SE,Coyle SM,Lowry SF,In vivo endotoxin synchronizes and suppresses clock gene expression in human peripheral blood leukocytesCrit Care MedYear: 20103875175810.1097/CCM.0b013e3181cd131c20081528
Yamamura Y,Yano I,Kudo T,Shibata S,Time-dependent inhibitory effect of lipopolysaccharide injection on Per1 and Per2 gene expression in the mouse heart and liverChronobiol IntYear: 20102721323210.3109/0742052100376911120370466
Petrzilka S,Taraborrelli C,Cavadini G,Fontana A,Birchler T,Clock gene modulation by TNF-alpha depends on calcium and p38 MAP kinase signalingJ Biol RhythmsYear: 20092428329410.1177/074873040933657919625730
Okada K,Yano M,Doki Y,Azama T,Iwanaga H,Miki H,Nakayama M,Miyata H,Takiguchi S,Fujiwara Y,Yasuda T,Ishida N,Monden M,Injection of LPS causes transient suppression of biological clock genes in ratsJ Surg ResYear: 200814551210.1016/j.jss.2007.01.01018279697
Cavadini G,Petrzilka S,Kohler P,Jud C,Tobler I,Birchler T,Fontana A,TNF-alpha suppresses the expression of clock genes by interfering with E-box-mediated transcriptionProc Natl Acad Sci USAYear: 2007104128431284810.1073/pnas.070146610417646651
Nishii K,Yamanaka I,Yasuda M,Kiyohara YB,Kitayama Y,Kondo T,Yagita K,Rhythmic post-transcriptional regulation of the circadian clock protein mPER2 in mammalian cells: a real-time analysisNeurosci LettYear: 2006401444810.1016/j.neulet.2006.03.02216580135
Izumo M,Johnson CH,Yamazaki S,Circadian gene expression in mammalian fibroblasts revealed by real-time luminescence reporting: temperature compensation and dampingProc Natl Acad Sci USAYear: 2003100160891609410.1073/pnas.253631310014657355
Yagita K,Tamanini F,van Der Horst GT,Okamura H,Molecular mechanisms of the biological clock in cultured fibroblastsScienceYear: 200129227828110.1126/science.105954211303101
Zanello SB,Jackson DM,Holick MF,Expression of the circadian clock genes clock and period1 in human skinJ Invest DermatolYear: 200011575776010.1046/j.1523-1747.2000.00121.x10998156
Haimovich B,Reddell MT,Calvano JE,Calvano SE,Macor MA,Coyle SM,Lowry SF,A novel model of common Toll-like receptor 4- and injury-induced transcriptional themes in human leukocytesCrit CareYear: 201014R17710.1186/cc928320929567


[Figure ID: F1]
Figure 1 

Presence of typical clock proteins in synovial tissue. Results of patients with osteoarthritis (OA) and rheumatoid arthritis (RA) are demonstrated. Nuclei are stained in blue with DAPI. The red staining is specific for the individual clock protein. Control staining is not given but yielded slides with negative results (only DAPI staining of nuclei is visible). Abbreviations: BMAL-1, brain and muscle arnt-like-1; DAPI, 4'-6-Diamidino-2-phenylindole; OA, osteoarthritis; Per, period homologue of Drosophila period; RA, rheumatoid arthritis.

[Figure ID: F2]
Figure 2 

Density of cells positive for typical clock proteins. A) Density of clock protein - positive cells in synovial tissue of patients with rheumatoid arthritis (RA) and osteoarthritis (OA). *P < 0.05 vs. RA; aP < 0.10 vs. RA. B) Density of cells positive for BMAL-1 (left panel) and Period 1 (Per1, right panel) over time. Synovial tissue was obtained from healthy subjects (HS, green) and patients with OA (black) and RA (red) at different time points during the day (time of operation start was grouped at 8:00 am, 11:00 am, 1:00 pm and 3:00 pm). Symbols in A) and B) indicate the mean value of cellular density of 17 randomly chosen high power fields from stained tissue of one individual patient. For example, this staining included n = 12 healthy subjects at time point 8:00 am. The correlation coefficient of cubic regression is given.

[Figure ID: F3]
Figure 3 

mRNA of selected molecular clocks over time in synovial fibroblasts. Results of patients with osteoarthritis (n = 6) and rheumatoid arthritis (n = 7) are demonstrated. One symbol represents the median value of mRNA of synovial fibroblast cultures of all included patients. The yellow area depicts the increase of the curve at different time points during an observation time of 72 hours. Typically mRNA starts with a huge peak after serum shock synchronization, which soon dies down. Abbreviations see legend to Figure 1.

[Figure ID: F4]
Figure 4 

Modulation by IL-1β and TNF of mRNA of clock proteins over time. Results from experiments with synovial fibroblasts of patients with osteoarthritis are shown (n = 6). A) Mean of mRNA of molecular clock and influence of IL-1β (1 ng/ml) and TNF (1 ng/ml). Of every patient, the average value of mRNA was calculated from 36 time points during an observation period of 72 hours. The Box plot is generated from n = 6 median values of osteoarthritis patients. Box plots give the 10th, 25th, 50th (median), 75th and 90th percentiles. **P < 0.01, ##P < 0.001 vs. respective control (Co). B) mRNA of selected molecular clocks over time in synovial fibroblasts of patients with osteoarthritis (n = 6). One symbol represents the median value of mRNA of synovial fibroblast cultures of the six patients at a given time point. The green control line is given for comparison (see Figure 3). Abbreviations see legend to Figure 1.

[Figure ID: F5]
Figure 5 

Modulation by IL-1β and TNF of mRNA of clock proteins over time. Results of experiments with synovial fibroblasts of patients with rheumatoid arthritis are shown (n = 7). A) Mean of mRNA of molecular clock and influence of IL-1β (1 ng/ml) and TNF (1 ng/ml). Of every patient, the average value of mRNA was calculated from 36 time points during an observation period of 72 hours. The Box plot is generated from n = 7 median values of rheumatoid arthritis patients. Box plots give the 10th, 25th, 50th (median), 75th and 90th percentiles. *P < 0.05, **P < 0.01, #P < 0.005, ##P < 0.001 vs. respective control (Co). B) mRNA of selected molecular clocks over time in synovial fibroblasts of patients with rheumatoid arthritis (n = 7). One symbol represents the median value of mRNA of synovial fibroblast cultures of the seven patients at a given time point. The green control line is given for comparison (see Figure 3). Abbreviations see legend to Figure 1.

[Figure ID: F6]
Figure 6 

Modulation by IL-1β and TNF of clock proteins in synovial fibroblasts. Abbreviations see legend to Figure 1. Box plots give the 10th, 25th, 50th (median), 75th and 90th percentiles. A) Mean of mRNA of Period 1 and Period 2 and dose-dependent influence of IL-1β and TNF (both ng/ml) on MH7A synovial fibroblasts. Effects on CLOCK and BMAL-1 are demonstrated in Additional file 2 Figure S2. The Box Plots are generated from at least 12 independent experiments over 36 hours (n = 19 for IL-1β; n = 12 for TNF). *P < 0.05, #P < 0.005, ##P < 0.001 vs. highest concentration. B) Influence of IL-1β and TNF (both 1 ng/ml) on elapsed time to first BMAL-1 mRNA peak after synchronization. Every symbol represents the time to first peak of one patient during 72 hours of observation (sample interval two hours). *P < 0.05, ##P < 0.001 vs. control (Co).

[TableWrap ID: T1] Table 1 

Characteristics of patients

Osteoarthritis Rheumatoid arthritis
number 17 17
age (yr) 68.8 ± 1.6 62.1 ± 3.0
sex (f/m) 14/3 13/4
C-reactive protein (mg/l) 9.4 ± 4.1 40.1 ± 14.6*
erythrocyte sedimentation rate (mm) 12.4 ± 2.6 41.5 ± 9.2*
 prednisolone (%) N.A. 88.0
 daily prednisolone (mg/d) N.A. 4.3 ± 0.5
 methotrexate (%) N.A. 35.3
 anti-TNF therapy (%) N.A. 5.9
 leflunomide (%) N.A. 29.4
 cyclosporin A (%) N.A. 5.9
 peripherally acting opioidergic drugs (%) 41.2 35.3
 Non-steroidal antiinflammatory drugs (%) 70.6 64.7

*P < 0.05 for the comparison vs. osteoarthritis. Abbreviations: N.A., not applicable.

Data are given as means ± SEM, percentages in parentheses, and ranges in brackets

Article Categories:
  • Research Article

Previous Document:  KO(t)Bu Mediated Synthesis of Phenanthridinones and Dibenzoazepinones.
Next Document:  Dexamethasone-Induced Eosinopenia is Associated with Lower Progesterone Production in Cattle.